Fractyl Health
GUTS

Fractyl Health (GUTS) analyst forecast and price target

Analyst forecast

Buy

Consensus of 6 analyst ratings

Buy
5
Hold
1
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
Craig-HallumInitiated CoverageBuy$4.00Jul 1, 2026
HC Wainwright & Co.MaintainedBuy$8.00Jun 4, 2026
HC Wainwright & Co.MaintainedBuy$8.00Apr 24, 2026
Canaccord GenuityMaintainedBuy$8.00Mar 26, 2026
Morgan StanleyDowngradedOverweight → Equal-Weight$2.00 from $8.00Jan 30, 2026
HC Wainwright & Co.MaintainedBuy$8.00Dec 2, 2025
Canaccord GenuityMaintainedBuy$8.00 from $6.00Nov 21, 2025
HC Wainwright & Co.MaintainedBuy$8.00 from $9.00Sep 26, 2025
HC Wainwright & Co.Initiated CoverageBuy$9.00Sep 15, 2025
Ladenburg ThalmannInitiated CoverageBuy$3.60Aug 28, 2025
Canaccord GenuityMaintainedBuy$6.00 from $12.00Aug 14, 2025
Canaccord GenuityInitiated CoverageBuy$12.00Apr 15, 2025
Morgan StanleyMaintainedOverweight$10.00 from $18.00Feb 3, 2025
Evercore ISI GroupInitiated CoverageOutperformFeb 28, 2024
Morgan StanleyInitiated CoverageOverweight$18.00Feb 27, 2024

Frequently asked questions

  • Is GUTS a buy, sell, or hold?

    Analysts covering Fractyl Health currently average a Buy rating: 5 buy, 1 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on GUTS?

    On Jul 1, 2026, Craig-Hallum initiated coverage of Fractyl Health at Buy with a price target of $4.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.